• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常的尿酸分数排泄可识别低钠血症患者的渗透压复位。

Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

机构信息

Department of Medicine, Winthrop-University Hospital, Mineola, New York, USA.

出版信息

J Nephrol. 2012 Sep-Oct;25(5):833-8. doi: 10.5301/jn.5000074.

DOI:10.5301/jn.5000074
PMID:22307440
Abstract

BACKGROUND

Reset osmostat (RO) occurs in 36% of patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH) and is not often considered when evaluating hyponatremic patients. Patients with RO are not usually treated, but recent awareness that symptoms are associated with mild hyponatremia creates a therapeutic dilemma. We encountered patients with hyponatremia, hypouricemia and high urine sodium concentration (UNa), who had normal fractional excretion (FE) of urate and excreted dilute urines that were consistent with RO. We decided to test whether a normal FEurate in nonedematous hyponatremia irrespective of UNa or serum urate would identify patients with RO.

METHODS

We determined FEurate in nonedematous hyponatremic patients. A diagnosis of RO was made if urine osmolality (Uosm) was <200 mOsm/kg in a random urine. We performed a modified water-loading test in patients with a normal FEurate whose random Uosm was >200 mOsm/kg.

RESULTS

All nonedematous hyponatremic patients with FEurate of 4%-11% had RO, as determined by Uosm <200 mOsm/kg on a random urine collection in 8 patients, or after a modified water-loading test in 6 patients. Plasma antidiuretic hormone (ADH) in 4 patients was undetectable at <1 pg/mL during water-loading. Nine patients had baseline concentrated urine, 12 had UNa >20 mmol/L, 9 were hypouricemic, yet all had a normal FEurate. Comorbidities were similar to those reported in RO.

CONCLUSIONS

RO, a benign form of SIADH, occurs commonly. A normal FEurate in a nonedematous hyponatremic patient is highly suggestive of RO. Determining FEurate is superior to serum urate. The therapeutic dilemma for RO must be resolved.

摘要

背景

重置渗透压感受器(RO)在抗利尿激素分泌不当综合征(SIADH)患者中占 36%,在评估低钠血症患者时通常不会考虑到这一点。RO 患者通常不需要治疗,但最近发现症状与轻度低钠血症有关,这就产生了一个治疗上的困境。我们遇到了一些低钠血症、低尿酸血症和高尿钠浓度(UNa)的患者,他们的尿酸分数排泄(FE)正常,且排出的尿液稀释,符合 RO 的特征。我们决定测试在非水肿性低钠血症中,无论 UNa 或血清尿酸如何,正常的 FEurate 是否可以识别 RO 患者。

方法

我们测定了非水肿性低钠血症患者的 FEurate。如果随机尿 Uosm<200 mOsm/kg,则诊断为 RO。对于 FEurate 正常且随机 Uosm>200 mOsm/kg 的患者,我们进行了改良的水负荷试验。

结果

8 例患者的随机尿 Uosm<200 mOsm/kg,6 例患者进行了改良水负荷试验,所有 4%至 11%的 FEurate 的非水肿性低钠血症患者均被确定为 RO。4 例患者在水负荷期间,ADH 不可检测,<1 pg/mL。9 例患者有基线浓缩尿,12 例患者有 UNa>20 mmol/L,9 例患者低尿酸血症,但所有患者的 FEurate 均正常。合并症与 RO 报道的相似。

结论

RO 是一种良性的 SIADH,很常见。非水肿性低钠血症患者的正常 FEurate 高度提示 RO。测定 FEurate 优于血清尿酸。RO 的治疗困境必须得到解决。

相似文献

1
Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.正常的尿酸分数排泄可识别低钠血症患者的渗透压复位。
J Nephrol. 2012 Sep-Oct;25(5):833-8. doi: 10.5301/jn.5000074.
2
High Prevalence of Renal Salt Wasting Without Cerebral Disease as Cause of Hyponatremia in General Medical Wards.综合医疗病房中以肾脏失盐而非脑部疾病为主要原因导致低钠血症的高发生率。
Am J Med Sci. 2018 Jul;356(1):15-22. doi: 10.1016/j.amjms.2018.03.020. Epub 2018 Apr 7.
3
Identifying Different Causes of Hyponatremia With Fractional Excretion of Uric Acid.通过尿酸排泄分数鉴别低钠血症的不同病因。
Am J Med Sci. 2016 Oct;352(4):385-390. doi: 10.1016/j.amjms.2016.05.035. Epub 2016 Jul 6.
4
Differentiating syndrome of inappropriate ADH, reset osmostat, cerebral/renal salt wasting using fractional urate excretion.利用尿酸排泄分数鉴别抗利尿激素分泌不当综合征、渗透压调定点重置、脑/肾性盐耗综合征。
J Pediatr Endocrinol Metab. 2020 Nov 12;34(1):137-140. doi: 10.1515/jpem-2020-0379. Print 2021 Jan 27.
5
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.口服血管加压素V2受体拮抗剂VPA - 985纠正肝硬化或抗利尿激素分泌不当综合征低钠血症患者期间溶质排泄的差异。
J Lab Clin Med. 2001 Jul;138(1):18-21. doi: 10.1067/mlc.2001.116025.
6
Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone.抗利尿激素分泌异常综合征的临床实验室评估
Clin J Am Soc Nephrol. 2008 Jul;3(4):1175-84. doi: 10.2215/CJN.04431007. Epub 2008 Apr 23.
7
Evidence that chronicity of hyponatremia contributes to the high urate clearance observed in the syndrome of inappropriate antidiuretic hormone secretion.低钠血症的慢性状态导致抗利尿激素分泌不当综合征中观察到的高尿酸清除率的证据。
Am J Kidney Dis. 2000 Oct;36(4):745-51. doi: 10.1053/ajkd.2000.17623.
8
More on renal salt wasting without cerebral disease: response to saline infusion.无脑部疾病的肾性失盐:对盐水输注的反应
Clin J Am Soc Nephrol. 2009 Feb;4(2):309-15. doi: 10.2215/CJN.02740608.
9
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH).抗利尿激素分泌不当综合征(SIADH)
Semin Nephrol. 2009 May;29(3):239-56. doi: 10.1016/j.semnephrol.2009.03.005.
10
Hyponatremia and hypouricemia: differentiation from SIADH.低钠血症和低尿酸血症:与抗利尿激素分泌异常综合征的鉴别
Clin Nephrol. 1990 Apr;33(4):174-8.

引用本文的文献

1
Chronic Hyponatremia: The Role of Reset Osmostat in Patients with Suspected SIAD.慢性低钠血症:渗透压调定点重设在疑似抗利尿激素分泌异常综合征患者中的作用
J Clin Med. 2024 Jun 17;13(12):3538. doi: 10.3390/jcm13123538.
2
High prevalence of renal salt wasting induced by haptoglobin-related protein without signal peptide is linked to new syndrome of salt wasting in Alzheimer disease.无信号肽的触珠蛋白相关蛋白诱导的肾性盐耗竭高患病率与阿尔茨海默病新的盐耗竭综合征有关。
Kidney Res Clin Pract. 2024 Jan;43(1):33-46. doi: 10.23876/j.krcp.23.092. Epub 2023 Nov 2.
3
A Conspectus of Euvolemic Hyponatremia, Its Various Etiologies, and Treatment Modalities: A Comprehensive Review of the Literature.
等渗性低钠血症及其各种病因和治疗方式概述:文献综述
Cureus. 2023 Aug 12;15(8):e43390. doi: 10.7759/cureus.43390. eCollection 2023 Aug.
4
Haptoglobin-Related Protein without Signal Peptide as Biomarker of Renal Salt Wasting in Hyponatremia, Hyponatremia-Related Diseases and as New Syndrome in Alzheimer's Disease.无信号肽的触珠蛋白相关蛋白作为低钠血症、低钠血症相关疾病和阿尔茨海默病中新综合征的肾盐丢失的生物标志物。
Biomolecules. 2023 Apr 1;13(4):638. doi: 10.3390/biom13040638.
5
New Approach to Hyponatremia: High Prevalence of Cerebral/Renal Salt Wasting, Identification of Natriuretic Protein That Causes Salt Wasting.低钠血症的新方法:脑/肾性失盐的高患病率,导致失盐的利钠蛋白的鉴定。
J Clin Med. 2022 Dec 15;11(24):7445. doi: 10.3390/jcm11247445.
6
Differential diagnosis between syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome in children over 1 year: proposal for a simple algorithm.1 岁以上儿童抗利尿激素分泌不当综合征与脑/肾盐耗综合征的鉴别诊断:提出一个简单的算法。
Pediatr Nephrol. 2022 Jul;37(7):1469-1478. doi: 10.1007/s00467-021-05250-1. Epub 2021 Sep 1.
7
Reset Osmostat: Facts and Controversies.重置渗透压调节器:事实与争议
Indian J Nephrol. 2019 Jul-Aug;29(4):232-234. doi: 10.4103/ijn.IJN_307_17.
8
Determining Fractional Urate Excretion Rates in Hyponatremic Conditions and Improved Methods to Distinguish Cerebral/Renal Salt Wasting From the Syndrome of Inappropriate Secretion of Antidiuretic Hormone.低钠血症状态下尿酸排泄分数率的测定以及区分脑性/肾性失盐与抗利尿激素分泌不当综合征的改进方法。
Front Med (Lausanne). 2018 Nov 30;5:319. doi: 10.3389/fmed.2018.00319. eCollection 2018.
9
Reset Osmostat: A Challenging Case of Hyponatremia.重置渗透压调节中枢:一例具有挑战性的低钠血症病例
Case Rep Med. 2018 Nov 4;2018:5670671. doi: 10.1155/2018/5670671. eCollection 2018.
10
Application of established pathophysiologic processes brings greater clarity to diagnosis and treatment of hyponatremia.应用已确立的病理生理过程能使低钠血症的诊断和治疗更加清晰明了。
World J Nephrol. 2017 Mar 6;6(2):59-71. doi: 10.5527/wjn.v6.i2.59.